TransCode Therapeutics, Inc.
RNAZ
$8.95
-$0.34-3.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.84M | 7.37M | 11.57M | 5.81M | 1.88M |
| Total Receivables | 198.30K | 176.10K | 322.40K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 476.20K | 90.80K | 211.00K | 342.30K | 529.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.24M | 600.00K | 941.80K | 940.00K | 1.21M |
| Total Current Assets | 4.75M | 8.24M | 13.04M | 7.09M | 3.61M |
|
|
|||||
| Total Current Assets | 4.75M | 8.24M | 13.04M | 7.09M | 3.61M |
| Net Property, Plant & Equipment | 19.90K | 24.70K | 38.10K | 89.30K | 211.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 455.70K | -- | 111.90K | 111.90K | 111.90K |
| Total Assets | 5.23M | 8.27M | 13.19M | 7.29M | 3.94M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 2.97M | 1.57M | 2.51M | 2.71M | 2.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 38.30K | 152.50K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 25.40K | -- |
| Total Other Current Liabilities | -- | -- | -- | 25.40K | -- |
| Total Current Liabilities | 2.97M | 1.57M | 2.51M | 2.77M | 2.28M |
|
|
|||||
| Total Current Liabilities | 2.97M | 1.57M | 2.51M | 2.77M | 2.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 832.90K | 553.70K | 392.00K | 6.54M | -- |
| Total Liabilities | 3.80M | 2.12M | 2.90M | 9.31M | 2.28M |
|
|
|||||
| Common Stock & APIC | 85.85M | 85.71M | 85.58M | 61.18M | 58.91M |
| Retained Earnings | -84.42M | -79.56M | -75.29M | -63.20M | -57.26M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.43M | 6.15M | 10.29M | -2.02M | 1.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.43M | 6.15M | 10.29M | -2.02M | 1.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.43M | 6.15M | 10.29M | -2.02M | 1.65M |
|
|
|||||